Autism presents significant challenges for clinical research and biomarker development due to behavioral heterogeneity and reliance on clinician- and caregiver-report measures that are limited in sensitivity, objectivity, and scalability. Biomarkers offer a complementary approach by providing biologically grounded, standardized, and potentially more sensitive indicators of the autism phenotype....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for audiology practice; this is a broad autism biomarker review with no direct hearing or vestibular clinical implications beyond awareness that autism research is evolving toward more objective biological measures.
As auditory processing and sensory sensitivity are frequently observed in autism, advances in autism biomarker research could eventually inform more objective audiological assessment tools and co-management strategies.
- 01Review covers progress in large-scale biological marker research consortia for autism (2026).
- 02Key challenge highlighted: behavioral variability and reliance on subjective clinician/caregiver reports.
- 03Aims to chart paths forward for more objective, biology-based autism diagnosis and stratification.
- 04Published in Biological Psychiatry; primarily relevant to researchers rather than clinical audiologists.
- 05Indirect relevance to audiology via auditory processing and sensory sensitivity in autism.
Behavioral heterogeneity and reliance on clinician/caregiver reporting are major obstacles to autism biomarker development.
opinionsupported- PMID
- 42595244
- DOI
- 10.1016/j.biopsych.2026.08.005.
- Journal
- Biological Psychiatry
- Publication type
- review
- Evidence level
- 5
- Population
- Review of large-scale biomarker consortium studies in autism spectrum disorder
- Intervention
- Large-scale biomarker consortia approaches in autism research
Primary outcomes
Progress and challenges in autism biomarker development; Paths forward for biomarker-based autism stratification